Metabolic Control and “Ideal” Outcomes in Liver Transplantation for Maple Syrup Urine Disease
- 17 June 2021
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 237, 59-64.e1
- https://doi.org/10.1016/j.jpeds.2021.06.028
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developmentsLiver Transplantation, 2016
- Living related versus deceased donor liver transplantation for maple syrup urine diseaseMolecular Genetics and Metabolism, 2016
- Liver Transplantation for Classical Maple Syrup Urine DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2014
- Liver transplantation for pediatric metabolic diseaseMolecular Genetics and Metabolism, 2014
- Biochemical correlates of neuropsychiatric illness in maple syrup urine diseaseJCI Insight, 2013
- Liver Transplantation for Classical Maple Syrup Urine Disease: Long-Term Follow-Up in 37 Patients and Comparative United Network for Organ Sharing ExperienceThe Journal of Pediatrics, 2012
- Health Status of Children Alive 10 Years after Pediatric Liver Transplantation Performed in the US and Canada: Report of the Studies of Pediatric Liver Transplantation ExperienceThe Journal of Pediatrics, 2011
- Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: A case seriesPediatric Transplantation, 2010
- Pediatric Liver Transplantation for Metabolic Liver Disease: Experience at King’s College HospitalTransplantation, 2009
- A Simple Estimate of Glomerular Filtration Rate in Children Derived From Body Length and Plasma CreatininePEDIATRICS, 1976